|
US6255059B1
(en)
|
1993-03-31 |
2001-07-03 |
Cadus Pharmaceutical Corporation |
Methods for identifying G protein coupled receptor effectors
|
|
US6100042A
(en)
|
1993-03-31 |
2000-08-08 |
Cadus Pharmaceutical Corporation |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
|
US7235648B1
(en)
|
1993-03-31 |
2007-06-26 |
Cadus Technologies, Inc. |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
|
US20030054402A1
(en)
|
1993-03-31 |
2003-03-20 |
Cadus Pharmaceutical Corporation |
Methods and compositions for identifying receptor effectors
|
|
US6864060B1
(en)
|
1993-03-31 |
2005-03-08 |
Cadus Technologies, Inc. |
Yeast cells expressing modified G proteins and methods of use therefor
|
|
US7416881B1
(en)
|
1993-03-31 |
2008-08-26 |
Cadus Technologies, Inc. |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
|
US6403305B1
(en)
*
|
1997-02-06 |
2002-06-11 |
Cornell Research Foundation, Inc. |
Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor
|
|
US6555339B1
(en)
*
|
1997-04-14 |
2003-04-29 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human protein-coupled receptors
|
|
US7119190B2
(en)
*
|
1997-04-14 |
2006-10-10 |
Arena Pharmaceuticals, Inc. |
Endogenous and non-endogenous versions of human G protein-coupled receptors
|
|
AU743259B2
(en)
*
|
1997-04-14 |
2002-01-24 |
Arena Pharmaceuticals, Inc. |
A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
|
|
AU8142598A
(en)
|
1997-06-11 |
1998-12-30 |
New York University |
Prenylcysteine carboxyl methyltransferase, dna encoding same, and a method of screening for inhibitors thereof
|
|
US6897066B1
(en)
*
|
1997-09-26 |
2005-05-24 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
|
AU9791198A
(en)
*
|
1997-10-07 |
1999-04-27 |
Cadus Pharmaceutical Corporation |
Yeast cells expressing modified g proteins and methods of use therefor
|
|
US6355473B1
(en)
|
1998-05-06 |
2002-03-12 |
Cadus Pharmaceutical Corp. |
Yeast cells having mutations in stp22 and uses therefor
|
|
US20020015967A1
(en)
*
|
1998-06-02 |
2002-02-07 |
Lauren Silverman |
Functional expression of adenosine receptors in yeast
|
|
FR2780512B1
(fr)
*
|
1998-06-25 |
2003-10-17 |
Lipha |
Utilisation de recepteurs de la famille rev-erb pour le criblage de substances utiles dans le traitement des dysfonctionnements du metabolisme lipidique
|
|
US7081360B2
(en)
|
1998-07-28 |
2006-07-25 |
Cadus Technologies, Inc. |
Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties
|
|
WO2000006722A1
(en)
*
|
1998-07-28 |
2000-02-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Eukaryotic cell-based gene interaction cloning
|
|
US6472151B1
(en)
*
|
1998-08-19 |
2002-10-29 |
Bristol-Myers Squibb Company |
Method of screening for compounds that modulate the activity of a molecular target
|
|
US7273747B2
(en)
|
1998-08-27 |
2007-09-25 |
Cadus Technologies, Inc. |
Cell having amplified signal transduction pathway responses and uses therefor
|
|
US6251605B1
(en)
|
1998-10-27 |
2001-06-26 |
Cadus Pharmaceutical Corporation |
Yeast cells having mutations in Cav1 and uses therefor
|
|
AU2030000A
(en)
*
|
1998-11-25 |
2000-06-13 |
Cadus Pharmaceutical Corporation |
Methods and compositions for identifying receptor effectors
|
|
DE19860833C1
(de)
*
|
1998-12-30 |
2000-09-07 |
Albrecht E Sippel |
Methode zur zellulären High-Throughput(Hochdurchsatz)-Detektion von Rezeptor-Liganden-Interaktionen
|
|
US6504008B1
(en)
*
|
1999-02-01 |
2003-01-07 |
Cadus Technologies, Inc. |
Cell based signal generation
|
|
US6555325B1
(en)
|
1999-06-14 |
2003-04-29 |
Cadus Technologies, Inc. |
System for detection of a functional interaction between a compound and a cellular signal transduction component
|
|
US7742877B1
(en)
*
|
1999-07-22 |
2010-06-22 |
Becton, Dickinson & Company |
Methods, apparatus and computer program products for formulating culture media
|
|
US7223533B2
(en)
|
1999-09-10 |
2007-05-29 |
Cadus Technologies, Inc. |
Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways
|
|
US6406863B1
(en)
*
|
2000-06-23 |
2002-06-18 |
Genetastix Corporation |
High throughput generation and screening of fully human antibody repertoire in yeast
|
|
JP2004520824A
(ja)
*
|
2000-12-01 |
2004-07-15 |
ワイス |
Ｒｇｓタンパク質のモジュレーターを検出するための方法および細胞
|
|
GB0030038D0
(en)
*
|
2000-12-08 |
2001-01-24 |
Univ Warwick |
Yeast-based assay
|
|
JP2004530117A
(ja)
*
|
2001-02-22 |
2004-09-30 |
プラエシス ファーマシューティカルズ インコーポレーテッド |
生物プロセスを調節するペプチドを同定する方法
|
|
CA2439383A1
(en)
*
|
2001-02-26 |
2002-09-06 |
Arena Pharmaceuticals, Inc. |
Endogenous and non-endogenous versions of human g protein-coupled receptors
|
|
EP1409656A4
(en)
*
|
2001-03-12 |
2005-01-12 |
Darley Pharmaceuticals Ltd |
SCREENING OF PHEROMONAL COMPOUNDS OF NON-STEROID AND NON-PEPTIDE INVERTEBRATE HAVING ACTIVITY MODULATING MITOGEN-ACTIVATED PROTEIN KINASE
|
|
US20070003980A1
(en)
*
|
2001-03-27 |
2007-01-04 |
Woods Daniel F |
Efficient methods to isolate effectors of proteins involved in olfactory or chemosensory pathways and efficient methods to use these effectors to alter organism olfaction, chemosensation, or behavior
|
|
US20100248268A1
(en)
*
|
2001-03-27 |
2010-09-30 |
Woods Daniel F |
Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses
|
|
CA2442581A1
(en)
*
|
2001-03-27 |
2002-10-03 |
Inscent, Inc. |
Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
|
|
JP4109123B2
(ja)
*
|
2001-05-09 |
2008-07-02 |
セルメド オンコロジー （ユーエスエイ）， インコーポレイテッド |
ペプチドデホルミラーゼ活性化プロドラッグ
|
|
AU2002317012A1
(en)
*
|
2001-06-28 |
2003-03-03 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Cellular reporter gene assay with a ligand amplifying feedback loop
|
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
|
NZ513755A
(en)
*
|
2001-08-24 |
2001-09-28 |
Ann Rachel Holmes |
Protein expression system in yeast comprising a vector encoding a heterologous membrane protein and its application in screening for drugs
|
|
US20060105377A1
(en)
*
|
2001-08-30 |
2006-05-18 |
Eglen Richard M |
Screening to optimize RNAi
|
|
EP1421385B1
(en)
*
|
2001-08-30 |
2016-06-29 |
DiscoveRx Corporation |
Genetic construct intracellular monitoring system
|
|
US7358043B2
(en)
|
2001-10-16 |
2008-04-15 |
Duke University |
Proteomic interaction and genomic action determinations in the presence of associated redox state conditions
|
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
|
EP1515985B1
(en)
|
2002-01-23 |
2013-01-02 |
Mohammed Raafat El-Gewely |
Methods of screening molecular libraries for active molecules that restore the function of mutant p53
|
|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
|
US7229762B2
(en)
*
|
2002-10-15 |
2007-06-12 |
Duke University Medical Center |
Proteomic screening for redox state dependent protein—protein interactions
|
|
EP1585807A4
(en)
*
|
2002-12-23 |
2006-05-24 |
Glycofi Inc |
STEROID RECEPTOR MODULATION OF GENE EXPRESSION
|
|
US20040209246A1
(en)
*
|
2003-04-15 |
2004-10-21 |
Agouron Pharmaceuticals, Inc. |
Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
|
|
US7718363B2
(en)
*
|
2003-04-25 |
2010-05-18 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
|
|
US20050112551A1
(en)
*
|
2003-11-24 |
2005-05-26 |
Agouron Pharmaceuticals, Inc. |
Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells
|
|
EP1689348B1
(en)
|
2003-12-05 |
2013-05-15 |
Children's Hospital Medical Center |
Oligosaccharide compositions and use thereof in the treatment of infection
|
|
JP5392992B2
(ja)
*
|
2007-03-30 |
2014-01-22 |
アズワン株式会社 |
自己リン酸化受容体のアゴニスト、アンタゴニストのスクリーニング方法、遺伝子組換え酵母
|
|
CA3187687A1
(en)
|
2007-09-14 |
2009-03-19 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US20090203149A1
(en)
*
|
2008-02-13 |
2009-08-13 |
General Electric Company |
Enhanced methods for gas and/or vapor phase analysis of biological assays
|
|
DE102008064553B4
(de)
*
|
2008-12-22 |
2015-05-13 |
Technische Universität Dresden |
Verfahren zum Nachweis und/oder zur Identifizierung hormonell wirksamer Substanzen
|
|
EP3336225B1
(en)
|
2010-07-16 |
2020-02-19 |
Adimab, LLC |
Antibody libraries
|
|
JP7146637B2
(ja)
*
|
2015-12-22 |
2022-10-04 |
アルブミディクス リミティド |
改善されたタンパク質発現株
|
|
WO2017112847A1
(en)
*
|
2015-12-22 |
2017-06-29 |
Albumedix A/S |
Improved protein expression strains
|
|
JP2019510510A
(ja)
|
2016-02-24 |
2019-04-18 |
アロマイクス・コーポレーション |
臭い（ｓｍｅｌｌ）、香り（ｓｃｅｎｔ）および食味（ｔａｓｔｅ）を検出するためのバイオセンサー
|
|
DK3642343T3
(en)
|
2017-06-20 |
2022-03-14 |
Albumedix Ltd |
Improved protein expression strains
|
|
US10209239B1
(en)
|
2017-08-16 |
2019-02-19 |
Aromyx Corporation |
Method of making an aromagraph comprising ectopic olfactory receptors
|
|
CN110904123B
(zh)
*
|
2019-01-07 |
2021-11-05 |
广西科学院 |
一种用于促进高产甘蔗糖蜜酒精发酵的菌株及其应用
|
|
WO2025008607A1
(en)
*
|
2023-07-06 |
2025-01-09 |
Imperial College Innovations Limited |
Determining the effects of modified peptides
|